Home›Companies›Healthcare›GeniPhys

GeniPhys, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 13, 2026·Suggest an edit

About GeniPhys

GeniPhys is a private company based in Indianapolis, Indiana, incorporated in 2021 in Delaware. It has reported $7,450,210 raised in two offerings on Form D since November 2022. Its chief executive is Andrew Eibling.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 29, 2026Feb 13, 2026$2,999,910of $5.5M target17$176KEquityRule 506(b)Form D ↗
Nov 15, 2022Nov 29, 2022$4,450,300of $6.1M target25$178KEquityRule 506(b)Form D ↗
Total, two offerings$7,450,210

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on GeniPhys's Form D filed Feb 13, 2026.

JD
John DeFord
Director
AE
Andrew Eibling
Chief Executive Officer and director
RN
R. Neff
Director

Earlier filings also listed Sherry Harbin (executive officer and director, last listed Nov 2022) and Scot Harbin (executive officer, last listed Nov 2022).

Sources

  1. SECGeniPhys, Inc. filing history